OUTSET MEDICAL INC (OM) Fundamental Analysis & Valuation

NASDAQ:OM • US6901452069

Current stock price

4.35 USD
+0.04 (+0.93%)
At close:
4.35 USD
0 (0%)
After Hours:

This OM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. OM Profitability Analysis

1.1 Basic Checks

  • OM had negative earnings in the past year.
  • OM had a negative operating cash flow in the past year.
  • In the past 5 years OM always reported negative net income.
  • OM had a negative operating cash flow in each of the past 5 years.
OM Yearly Net Income VS EBIT VS OCF VS FCFOM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 -50M -100M -150M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -30.87%, OM is in line with its industry, outperforming 42.02% of the companies in the same industry.
  • The Return On Equity of OM (-64.32%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -30.87%
ROE -64.32%
ROIC N/A
ROA(3y)-44.11%
ROA(5y)-40.31%
ROE(3y)-227.37%
ROE(5y)-156.73%
ROIC(3y)N/A
ROIC(5y)N/A
OM Yearly ROA, ROE, ROICOM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300 -400

1.3 Margins

  • OM has a Gross Margin of 39.13%. This is in the lower half of the industry: OM underperforms 69.15% of its industry peers.
  • In the last couple of years the Gross Margin of OM has grown nicely.
  • OM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.39%
GM growth 5YN/A
OM Yearly Profit, Operating, Gross MarginsOM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. OM Health Analysis

2.1 Basic Checks

  • OM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, OM has less shares outstanding
  • OM has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for OM has been reduced compared to a year ago.
OM Yearly Shares OutstandingOM Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
OM Yearly Total Debt VS Total AssetsOM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • OM has an Altman-Z score of -5.27. This is a bad value and indicates that OM is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -5.27, OM is not doing good in the industry: 73.94% of the companies in the same industry are doing better.
  • OM has a Debt/Equity ratio of 0.76. This is a neutral value indicating OM is somewhat dependend on debt financing.
  • OM has a worse Debt to Equity ratio (0.76) than 72.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Altman-Z -5.27
ROIC/WACCN/A
WACC6.44%
OM Yearly LT Debt VS Equity VS FCFOM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 6.67 indicates that OM has no problem at all paying its short term obligations.
  • The Current ratio of OM (6.67) is better than 85.11% of its industry peers.
  • OM has a Quick Ratio of 5.40. This indicates that OM is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of OM (5.40) is better than 80.85% of its industry peers.
Industry RankSector Rank
Current Ratio 6.67
Quick Ratio 5.4
OM Yearly Current Assets VS Current LiabilitesOM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. OM Growth Analysis

3.1 Past

  • OM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 79.22%, which is quite impressive.
  • Looking at the last year, OM shows a small growth in Revenue. The Revenue has grown by 5.09% in the last year.
  • Measured over the past years, OM shows a quite strong growth in Revenue. The Revenue has been growing by 19.08% on average per year.
EPS 1Y (TTM)79.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.86%
Revenue 1Y (TTM)5.09%
Revenue growth 3Y1.16%
Revenue growth 5Y19.08%
Sales Q2Q%-2.01%

3.2 Future

  • OM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.32% yearly.
  • OM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.24% yearly.
EPS Next Y47.95%
EPS Next 2Y25.28%
EPS Next 3Y18.67%
EPS Next 5Y14.32%
Revenue Next Year7.99%
Revenue Next 2Y9.58%
Revenue Next 3Y11.01%
Revenue Next 5Y11.24%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
OM Yearly Revenue VS EstimatesOM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
OM Yearly EPS VS EstimatesOM Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -20 -40 -60 -80

More info and screens

Find the best growth stocksShow best growing peers

0

4. OM Valuation Analysis

4.1 Price/Earnings Ratio

  • OM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year OM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OM Price Earnings VS Forward Price EarningsOM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OM Per share dataOM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6

4.3 Compensation for Growth

  • OM's earnings are expected to grow with 18.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.28%
EPS Next 3Y18.67%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. OM Dividend Analysis

5.1 Amount

  • No dividends for OM!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

OM Fundamentals: All Metrics, Ratios and Statistics

OUTSET MEDICAL INC

NASDAQ:OM (4/14/2026, 8:00:02 PM)

After market: 4.35 0 (0%)

4.35

+0.04 (+0.93%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-11
Earnings (Next)05-05
Inst Owners88.36%
Inst Owner Change0%
Ins Owners1.66%
Ins Owner Change4.79%
Market Cap79.65M
Revenue(TTM)119.48M
Net Income(TTM)-81.65M
Analysts83.08
Price Target10.71 (146.21%)
Short Float %11.43%
Short Ratio8.48
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-15.1%
Min EPS beat(2)-27.93%
Max EPS beat(2)-2.28%
EPS beat(4)1
Avg EPS beat(4)-61.52%
Min EPS beat(4)-232.87%
Max EPS beat(4)16.99%
EPS beat(8)3
Avg EPS beat(8)-28.11%
EPS beat(12)4
Avg EPS beat(12)-21.15%
EPS beat(16)5
Avg EPS beat(16)-17.87%
Revenue beat(2)1
Avg Revenue beat(2)-1.14%
Min Revenue beat(2)-7.47%
Max Revenue beat(2)5.19%
Revenue beat(4)3
Avg Revenue beat(4)1.33%
Min Revenue beat(4)-7.47%
Max Revenue beat(4)5.19%
Revenue beat(8)5
Avg Revenue beat(8)-1.92%
Revenue beat(12)7
Avg Revenue beat(12)-1.51%
Revenue beat(16)9
Avg Revenue beat(16)-1.48%
PT rev (1m)0%
PT rev (3m)-33.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.42%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.39%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.61%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.67
P/FCF N/A
P/OCF N/A
P/B 0.63
P/tB 0.63
EV/EBITDA N/A
EPS(TTM)-5.61
EYN/A
EPS(NY)-2.92
Fwd EYN/A
FCF(TTM)-2.57
FCFYN/A
OCF(TTM)-2.53
OCFYN/A
SpS6.53
BVpS6.93
TBVpS6.93
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -30.87%
ROE -64.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.13%
FCFM N/A
ROA(3y)-44.11%
ROA(5y)-40.31%
ROE(3y)-227.37%
ROE(5y)-156.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.39%
GM growth 5YN/A
F-Score6
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.38%
Cap/Sales 0.67%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.67
Quick Ratio 5.4
Altman-Z -5.27
F-Score6
WACC6.44%
ROIC/WACCN/A
Cap/Depr(3y)31.17%
Cap/Depr(5y)62.98%
Cap/Sales(3y)1.37%
Cap/Sales(5y)2.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.86%
EPS Next Y47.95%
EPS Next 2Y25.28%
EPS Next 3Y18.67%
EPS Next 5Y14.32%
Revenue 1Y (TTM)5.09%
Revenue growth 3Y1.16%
Revenue growth 5Y19.08%
Sales Q2Q%-2.01%
Revenue Next Year7.99%
Revenue Next 2Y9.58%
Revenue Next 3Y11.01%
Revenue Next 5Y11.24%
EBIT growth 1Y41.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year8.37%
EBIT Next 3Y15.83%
EBIT Next 5Y16.11%
FCF growth 1Y59.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y60.17%
OCF growth 3YN/A
OCF growth 5YN/A

OUTSET MEDICAL INC / OM Fundamental Analysis FAQ

What is the fundamental rating for OM stock?

ChartMill assigns a fundamental rating of 3 / 10 to OM.


Can you provide the valuation status for OUTSET MEDICAL INC?

ChartMill assigns a valuation rating of 0 / 10 to OUTSET MEDICAL INC (OM). This can be considered as Overvalued.


Can you provide the profitability details for OUTSET MEDICAL INC?

OUTSET MEDICAL INC (OM) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for OM stock?

The Earnings per Share (EPS) of OUTSET MEDICAL INC (OM) is expected to grow by 47.95% in the next year.